Vimarsana
Biggest News Aggregation in the World

Page 20 - Confidence Interval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Confidence Interval Today - Breaking & Trending Today

Low income associated with worse cardiovascular health in middle-aged adults - Vimarsana News

Low income associated with worse cardiovascular health in middle-aged adults

1. In this cross-sectional study, low-income middle-aged adults in the United States had increased rates of hypertension, diabetes, and cigarette use than their higher-income counterparts over the past two decades. 2. The prevalence of hypertension increased in low-income middle-aged adults while that of diabetes and obesity increased in their higher-income counterparts during the same period.

Weekly insulin icodec is more effective than daily basal insulin at reducing HbA1c - Vimarsana News

Weekly insulin icodec is more effective than daily basal insulin at reducing HbA1c

1. In this randomized controlled trial, insulin icodec demonstrated superior HbA1c reduction as compared to once-daily basal insulin analogs in insulin-naïve type two diabetes (T2D). 2. Insulin icodec showed improved treatment satisfaction and compliance as compared to once-daily basal insulin analogs in insulin naïve T2D. Evidence Rating Level: 1 (Excellent) Study Rundown: Two prior phase

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer - Vimarsana News

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer

/PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced that on December 15,...

The 2 Minute Medicine Podcast Episode 30 | 2 Minute Medicine - Vimarsana News

The 2 Minute Medicine Podcast Episode 30 | 2 Minute Medicine

Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description We begin this episode by discussing our article of the week from the New England

Traffic-related air pollution is associated with increased blood pressure - Vimarsana News

Traffic-related air pollution is associated with increased blood pressure

1. In this randomized crossover trial, mean systolic and diastolic blood pressures were higher for unfiltered drives at one hour and 24 hours after drive initiation, respectively. 2. Adjusted mean central retinal arteriolar equivalents (CRAE) were unchanged between filtered and unfiltered days. Evidence Rating Level: 1 (Excellent) Study Rundown: Traffic-related air pollution (TRAP) is an air